NCT02494284 - Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation | Biotech Hunter

Enrollment

364

Participants

Timeline

Start Date

December 22, 2015

Primary Completion Date

February 13, 2017

Study Completion Date

February 13, 2017

Conditions

Coronary Artery Disease

Interventions

DRUG

Clopidogrel

6-month DAPT followed by clopidogrel monotherapy

DRUG

Aspirin plus clopidogrel

standard long-term dual antiplatelet strategies (24-month DAPT followed by aspirin monotherapy)

Trial Locations (12)

Keimyung University Dongsan Medical Center, Daegu

Eulji University Hospital, Daejeon

Gangneung Asan Hospital, Gangneung

Inje University Ilsan Paik Hospital, Ilsan

Cheju Halla General Hospital, Jeju City

Asan Medical Center, Seoul

Kangbuk Samsung Medical Center, Seoul

Kyunghee University Medical Center, Seoul

SMA-SNU Boramae Medical Center, Seoul

The Catholic University of Korea St. Paul's Hospital, Seoul

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

Ulsan University Hospital, Ulsan